These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Patterns of antihypertensive therapy among patients with diabetes. Johnson ML, Singh H. J Gen Intern Med; 2005 Sep; 20(9):842-6. PubMed ID: 16117753 [Abstract] [Full Text] [Related]
9. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis. Wang Y, Chen B, Li Y, Zhang L, Wang Y, Yang S, Xiao X, Qin Q. J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513 [Abstract] [Full Text] [Related]
14. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M, Chen MM, Cheng X, Zhang X, Guo D, Peng Y, Ji YX, Chen J, She ZG, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang XJ, Wang X, Touyz RM, Xia J, Zhang BH, Huang X, Yuan Y, Loomba R, Liu PP, Li H. Circ Res; 2020 Jun 05; 126(12):1671-1681. PubMed ID: 32302265 [Abstract] [Full Text] [Related]
15. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right? Brooks JM, Chapman CG, Suneja M, Schroeder MC, Fravel MA, Schneider KM, Wilwert J, Li YJ, Chrischilles EA, Brenton DW, Brenton M, Robinson J. J Am Heart Assoc; 2018 May 30; 7(11):. PubMed ID: 29848495 [Abstract] [Full Text] [Related]
17. Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease. An J, Niu F, Sim JJ. Pharmacotherapy; 2021 Dec 30; 41(12):998-1008. PubMed ID: 34655484 [Abstract] [Full Text] [Related]
18. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Mohan A, Majd Z, Johnson ML, Essien EJ, Barner J, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM. Drugs Aging; 2023 Apr 30; 40(4):377-390. PubMed ID: 36847995 [Abstract] [Full Text] [Related]
19. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N, Interdisciplinary Chronic Disease Collaboration. JAMA Intern Med; 2018 Dec 01; 178(12):1681-1690. PubMed ID: 30422153 [Abstract] [Full Text] [Related]
20. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. Cooke CE, Fatodu H. J Manag Care Pharm; 2006 Oct 01; 12(8):649-55. PubMed ID: 17269843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]